PRMT5 associates with the FoXP3 homomer and when disabled enhances targeted p185ErbB2/neu tumor immunotherapy

Yasuhiro Nagai, Mei Q. Ji, Fuxiang Zhu, Yan Xiao, Yukinori Tanaka, Taku Kambayashi, Shigeyoshi Fujimoto, Michael M. Goldberg, Hongtao Zhang, Bin Li, Takuya Ohtani, Mark I. Greene

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'PRMT5 associates with the FoXP3 homomer and when disabled enhances targeted p185ErbB2/neu tumor immunotherapy'. Together they form a unique fingerprint.

Immunology and Microbiology